(OR) L’Oreal - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000120321
OR: Skincare, Makeup, Haircare, Fragrances
LOréal S.A. stands as a global leader in the beauty and personal care industry, operating through four key divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. The companys extensive portfolio includes skincare, makeup, haircare, fragrances, and hygiene products, catering to diverse consumer needs. Notably, LOréal has been at the forefront of innovation, investing heavily in research and development to maintain its competitive edge. Its commitment to sustainability is evident through various initiatives aimed at reducing environmental impact, enhancing its reputation as a responsible corporate entity.
LOréals brand portfolio is both expansive and prestigious, featuring names like Lancôme, Yves Saint Laurent Beauté, Kiehls, and Aesop, among others. These brands are distributed through a multi-channel network, including salons, retail stores, e-commerce platforms, and pharmacies, ensuring broad accessibility. The companys strategic acquisitions, such as the purchase of Aesop, have strengthened its position in the premium and niche markets, contributing to its global dominance in the beauty sector.
Headquartered in Clichy, France, LOréal was founded in 1909 and has since grown into a multinational corporation with operations in over 140 countries. Its presence spans various regions, with a significant focus on emerging markets where beauty and personal care demand is on the rise. The companys global supply chain and manufacturing capabilities support its extensive distribution network, ensuring efficient product delivery worldwide.
For the next three months, LOréals stock (OR:PA) is expected to trade within a range of €335 to €355. The 20-day SMA of €346.03 and 50-day SMA of €349.24 suggest a potential downtrend, while the 200-day SMA of €360.98 indicates a bearish crossover. The ATR of 10.41 signals moderate volatility. On the fundamental side, a forward P/E of 26.32 and P/S of 4.22 suggest expectations of future growth. However, geopolitical tensions and cost pressures could impact margins. The companys focus on innovation and sustainability may drive revenue growth, particularly in premium segments, potentially offsetting external challenges.
Additional Sources for OR Stock
OR Stock Overview
Market Cap in USD | 235,590m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
OR Stock Ratings
Growth Rating | 26.2 |
Fundamental | 67.4 |
Dividend Rating | 64.5 |
Rel. Strength | -22.5 |
Analysts | - |
Fair Price Momentum | 364.75 EUR |
Fair Price DCF | 428.12 EUR |
OR Dividends
Dividend Yield 12m | 1.91% |
Yield on Cost 5y | 2.98% |
Annual Growth 5y | 11.38% |
Payout Consistency | 99.9% |
OR Growth Ratios
Growth Correlation 3m | 49.7% |
Growth Correlation 12m | -70% |
Growth Correlation 5y | 62.6% |
CAGR 5y | 9.63% |
CAGR/Max DD 5y | 0.32 |
Sharpe Ratio 12m | -1.33 |
Alpha | -21.22 |
Beta | 0.105 |
Volatility | 26.73% |
Current Volume | 299.6k |
Average Volume 20d | 490.7k |
As of May 09, 2025, the stock is trading at EUR 375.35 with a total of 299,625 shares traded.
Over the past week, the price has changed by -2.83%, over one month by +11.22%, over three months by +11.59% and over the past year by -14.52%.
Yes, based on ValueRay Fundamental Analyses, L’Oreal (PA:OR) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 67.37 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OR as of May 2025 is 364.75. This means that OR is currently overvalued and has a potential downside of -2.82%.
L’Oreal has no consensus analysts rating.
According to ValueRays Forecast Model, OR L’Oreal will be worth about 393.9 in May 2026. The stock is currently trading at 375.35. This means that the stock has a potential upside of +4.95%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 376.2 | 0.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 393.9 | 5% |